|
1
|
Demedts IK, Demoor T, Bracke KR, Joos GF
and Brusselle GG: Role of apoptosis in the pathogenesis of COPD and
pulmonary emphysema. Respir Res. 7(53)2006.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Demedts IK, Brusselle GG, Bracke KR,
Vermaelen KY and Pauwels RA: Matrix metalloproteinases in asthma
and COPD. Curr Opin Pharmacol. 5:257–263. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Barnes PJ, Shapiro SD and Pauwels RA:
Chronic obstructive pulmonary disease: Molecular and
cellularmechanisms. Eur Respir J. 22:672–688. 2003.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pauwels RA, Buist AS, Calverley PM,
Jenkins CR and Hurd SS: GOLD Scientific Committee. Global strategy
for the diagnosis, management, and prevention of chronic
obstructive pulmonary disease. NHLBI/WHO global initiative for
chronic obstructive lung disease (GOLD) workshop summary. Am J
Respir Crit Care Med. 163:1256–1276. 2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pauwels RA and Rabe KF: Burden and
clinical features of chronic obstructive pulmonary disease (COPD).
Lancet. 364:613–620. 2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lahzami S and Aubert JD: Lung
transplantation for COPD-evidence-based. Swiss Med Wkly. 139:4–8.
2009.PubMed/NCBI
|
|
7
|
Chilosi M, Poletti V and Rossi A: The
pathogenesis of COPD and IPF: Distinct horns of the same devil?
Respir Res. 13(3)2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Houssaini A, Breau M, Kebe K, Abid S,
Marcos E, Lipskaia L, Rideau D, Parpaleix A, Huang J, Amsellem V,
et al: mTOR pathway activation drives lung cell senescence and
emphysema. JCI Insight. 3(pii: 93203)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Malone CD and Hannon GJ: Small RNAs as
guardians of the genome. Cell. 136:656–668. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Moazed D: Small RNAs in transcriptional
gene silencing and genome defence. Nature. 457:413–420.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Brosnan CA and Voinnet O: The long and the
short of noncoding RNAs. Curr Opin Cell Biol. 21:416–425.
2009.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mattick JS: Non-coding RNAs: The
architects of eukaryotic complexity. EMBO Rep. 2:986–991.
2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kim A, Zhao H, Ifrim I and Dean A:
Beta-globin intergenic transcription and histone acetylation
dependent on an enhancer. Mol Cell Biol. 27:2980–2986.
2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Managadze D, Rogozin IB, Chernikova D,
Shabalina SA and Koonin EV: Negative correlation between expression
level and evolutionary rate of long intergenic noncoding RNAs.
Genome Biol Evol. 3:1390–1404. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Krangel MS: T cell development: Better
living through chromatin. Nat Immunol. 8:687–694. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Srikantan V, Zou Z, Petrovics G, Xu L,
Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino
K, et al: PCGEM1, a prostate-specific gene, is overexpressed in
prostate cancer. Proc Natl Acad Sci USA. 97:12216–12221.
2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bussemakers MJ, van Bokhoven A, Verhaegh
GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N and Isaacs
WB: DD3: A new prostate-specific gene, highly overexpressed in
prostate cancer. Cancer Res. 59:5975–5979. 1999.PubMed/NCBI
|
|
19
|
Petrovics G, Zhang W, Makarem M, Street
JP, Connelly R, Sun L, Sesterhenn IA, Srikantan V, Moul JW and
Srivastava S: Elevated expression of PCGEM1, a prostate-specific
gene with cell growth-promoting function, is associated with
high-risk prostate cancer patients. Oncogene. 23:605–611.
2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Iacoangeli A, Lin Y, Morley EJ, Muslimov
IA, Bianchi R, Reilly J, Weedon J, Diallo R, Böcker W and Tiedge H:
BC200 RNA in invasive and preinvasive breast cancer.
Carcinogenesis. 25:2125–2133. 2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Taft RJ, Pang KC, Mercer TR, Dinger M and
Mattick JS: Non-coding RNAs: Regulators of disease. J Pathol.
220:126–139. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Klattenhoff CA, Scheuermann JC, Surface
LE, Bradley RK, Fields PA, Steinhauser ML, Ding H, Butty VL, Torrey
L, Haas S, et al: Braveheart, a long noncoding RNA required for
cardiovascular lineage commitment. Cell. 152:570–583.
2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189.
2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Johnson R: Long non-coding RNAs in
Huntington's disease neurodegeneration. Neurobiol Dis. 46:245–254.
2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Congrains A, Kamide K, Oguro R, Yasuda O,
Miyata K, Yamamoto E, Kawai T, Kusunoki H, Yamamoto H, Takeya Y, et
al: Genetic variants at the 9p21 locus contribute to
atherosclerosis through modulation of ANRIL and CDKN2A/B.
Atherosclerosis. 220:449–455. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tang W, Shen Z, Guo J and Sun S: Screening
of long non-coding RNA and TUG1 inhibits proliferation with TGF-β
induction in patients with COPD. Int J Chron Obstruct Pulmon Dis.
11:2951–2964. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li JY, Chen XX, Lu XH, Zhang CB, Shi QP
and Feng L: Elevated RBP4 plasma levels were associated with
diabetic retinopathy in type 2 diabetes. Biosci Rep. 38(pii:
BSR20181100)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li S, Mei Z, Hu HB and Zhang X: The lncRNA
MALAT1 contributes to non-small cell lung cancer development via
modulating miR-124/STAT3 axis. J Cell Physiol. 233:6679–6688.
2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sun C, Li S, Zhang F, Xi Y, Wang L, Bi Y
and Li D: Long non-coding RNA NEAT1 promotes non-small cell lung
cancer progression through regulation of miR-377-3p-E2F3 pathway.
Oncotarget. 7:51784–51814. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao
X, Chen WS and Li B: LncRNA-UCA1 exerts oncogenic functions in
non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett.
371:99–106. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Loewen G, Jayawickramarajah J, Zhuo Y and
Shan B: Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol.
7(90)2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yu G, Liu J, Xu K and Dong J: Uncoupling
protein 2 mediates resistance to gemcitabine-induced apoptosis in
hepatocellular carcinoma cell lines. Biosci Rep. 35(pii:
e00231)2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xia S, Ji R and Zhan W: Long noncoding RNA
papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3)
inhibits proliferation and invasion of glioma cells by suppressing
the Wnt/β-catenin signaling pathway. BMC Neurol.
17(30)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhong Y, Chen Z, Guo S, Liao X, Xie H,
Zheng Y, Cai B, Huang P, Liu Y, Zhou Q, et al: TUG1, SPRY4-IT1, and
HULC as valuable prognostic biomarkers of survival in cancer: A
PRISMA-compliant meta-analysis. Medicine (Baltimore).
96(e8583)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Perez DS, Hoage TR, Pritchett JR,
Ducharme-Smith AL, Halling ML, Ganapathiraju SC, Streng PS and
Smith DI: Long, abundantly expressed non-coding transcripts are
altered in cancer. Hum Mol Genet. 17:642–655. 2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Moseley ML, Zu T, Ikeda Y, Gao W,
Mosemiller AK, Daughters RS, Chen G, Weatherspoon MR, Clark HB,
Ebner TJ, et al: Bidirectional expression of CUG and CAG expansion
transcripts and intranuclear polyglutamine inclusions in
spinocerebellar ataxia type 8. Nat Genet. 38:758–769.
2006.PubMed/NCBI View
Article : Google Scholar
|
|
40
|
Standards for the diagnosis and care of
patients with chronic obstructive pulmonary disease. American
Thoracic Society. Am J Respir Crit Care Med 152: S77-S121,
1995.
|
|
41
|
Buist AS: Guidelines for the management of
chronic obstructive pulmonary disease. Respir Med. 96 (Suppl
C):S11–S16. 2002.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Jones PW, Quirk FH, Baveystock CM and
Littlejohns P: A self-complete measure of health status for chronic
airflow limitation. The St. George's Respiratory Questionnaire. Am
Rev Respir Dis. 145:1321–1327. 1992.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Seemungal TA, Donaldson GC, Paul EA,
Bestall JC, Jeffries DJ and Wedzicha JA: Effect of exacerbation on
quality of life in patients with chronic obstructive pulmonary
disease. Am J Respir Crit Care Med. 157:1418–1422. 1998.PubMed/NCBI View Article : Google Scholar
|
|
44
|
De Smet EG, Mestdagh P, Vandesompele J,
Brusselle GG and Bracke KR: Non-coding RNAs in the pathogenesis of
COPD. Thorax. 70:782–791. 2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Cao G, Zhang J, Wang M, Song X, Liu W, Mao
C and Lv C: Differential expression of long non-coding RNAs in
bleomycin-induced lung fibrosis. Int J Mol Med. 32:355–364.
2013.PubMed/NCBI View Article : Google Scholar
|
|
46
|
McKiernan PJ, Molloy K, Cryan SA,
McElvaney NG and Greene CM: Long noncoding RNA are aberrantly
expressed in vivo in the cystic fibrosis bronchial epithelium. Int
J Biochem Cell Biol. 52:184–191. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Bi H, Zhou J, Wu D, Gao W, Li L, Yu L, Liu
F, Huang M, Adcock IM, Barnes PJ and Yao X: Microarray analysis of
long non-coding RNAs in COPD lung tissue. Inflamm Res. 64:119–126.
2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Borovikova LV, Ivanova S, Zhang M, Yang H,
Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW and Tracey
KJ: Vagus nerve stimulation attenuates the systemic inflammatory
response to endotoxin. Nature. 405:458–462. 2000.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Qi JD, Chu YF, Zhang GY, Li HJ, Yang DD
and Wang Q: Down-regulated LncR-MALAT1 suppressed cell
proliferation and migration by inactivating autophagy in bladder
cancer. RSC Adv. 8:31019–31027. 2018.
|
